Analysis-U.S. Midterms Dampen Big Pharma Hopes For Drug Price Policy Change

Analysis-U.S. Midterms Dampen Big Pharma Hopes For Drug Price Policy Change

By Ahmed Aboulenein WASHINGTON (Reuters) – The divided U.S. Congress after the November midterm elections undermines pharmaceutical companies who want to weaken a new law that allows the government to negotiate drug prices, Republican strategists, policy experts and pharmaceutical executives say. Democratic President Joe Biden’s signature Inflation Reduction Act, which Democrats passed in August against…

Read More
Italy Court Rejects Google's Appeal Against Watchdog Fine, Accepts Apple's One

Italy Court Rejects Google’s Appeal Against Watchdog Fine, Accepts Apple’s One

MILAN (Reuters) – An Italian administrative court on Friday rejected an appeal by Alphabet’s Google against a decision by Italy’s antitrust authority to fine the group, but accepted iPhone maker Apple’s appeal against the watchdog’s ruling. Last year, Italy’s antitrust regulator fined Google and Apple 10 million euros ($10.36 million) each, claiming that the two…

Read More